-+ 0.00%
-+ 0.00%
-+ 0.00%

Craig-Hallum Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $62

Benzinga·07/28/2026 18:01:52
語音播報
Craig-Hallum analyst Chase Knickerbocker maintains Eton Pharmaceuticals (NASDAQ:ETON) with a Buy and raises the price target from $40 to $62.